AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 35 filers reported holding AXCELLA HEALTH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,575 | -54.6% | 16,398 | 0.0% | 0.00% | – |
| Q1 2023 | $7,871 | +30173.1% | 16,398 | +20923.1% | 0.00% | – |
| Q4 2022 | $26 | – | 78 | +44.4% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 54 | -81.9% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 298 | -54.4% | 0.00% | – |
| Q3 2021 | $2,000 | -84.6% | 654 | -80.4% | 0.00% | – |
| Q2 2021 | $13,000 | -87.3% | 3,330 | -84.5% | 0.00% | – |
| Q1 2021 | $102,000 | +72.9% | 21,494 | +87.7% | 0.00% | – |
| Q4 2020 | $59,000 | +34.1% | 11,449 | +20.5% | 0.00% | – |
| Q3 2020 | $44,000 | +76.0% | 9,499 | +109.0% | 0.00% | – |
| Q2 2020 | $25,000 | +316.7% | 4,545 | +176.0% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 1,647 | -30.1% | 0.00% | – |
| Q4 2019 | $10,000 | 0.0% | 2,357 | +34.8% | 0.00% | – |
| Q3 2019 | $10,000 | -28.6% | 1,749 | +16.5% | 0.00% | – |
| Q2 2019 | $14,000 | – | 1,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 2,807,981 | $14,573,000 | 5.70% |
| Flagship Pioneering Inc. | 12,548,414 | $65,126,000 | 1.19% |
| Artal Group S.A. | 712,500 | $3,698,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 30,713 | $159,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 132,915 | $690,000 | 0.01% |
| Virtu Financial LLC | 15,682 | $81,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 187,122 | $971,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62,467 | $324,000 | 0.01% |
| FMR LLC | 5,631,132 | $29,226,000 | 0.00% |
| MARSHALL WACE, LLP | 60,307 | $313,000 | 0.00% |